Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 1101 - 1110 of 2454
  • University of Pennsylvania Carey Law School establishes the Morgan Lewis Impact Fund for Racial Justice

    The $250,000 fund will provide financial support to racial justice and anti-racism efforts at the Law School, expanding initiatives to advance racial justice in the classroom, in the community, and in the profession.

    FULL STORY AT Penn Carey Law

  • Penn Medicine CAREs Serve Saturday

    In the Serve Saturday outreaches, volunteers gather in underserved areas in the city to lead a variety of programs, ranging from giving out groceries, paying for gas and offering SEPTA key cards, to cleaning public spaces. With support from a Penn Medicine CAREs grant, Serve Saturday will be able to extend their services to the Port Richmond area in North Philadephia.

    FULL STORY AT Penn Medicine News

  • Michael Kahana leads team awarded $3.4 million to study the treatment of memory loss in patients with traumatic brain injury

    A team of neuroscientists led by Michael Jacob Kahana, Edmund J. and Louise W. Kahn Term Professor of Psychology and and Director of the Computational Memory Lab, are developing and testing new therapeutics for treating memory loss in patients with traumatic brain injury, alongside basic research on electrophysiological biomarkers of memory at Penn.

    FULL STORY AT Penn Arts & Sciences

  • Antibody infusion treatment offers peace of mind for people at high risk for severe illness from COVID-19

    Monoclonal antibodies, laboratory-made proteins that effectively boost the immune system’s ability to fight the COVID-19 virus, is shown to significantly reduce the risk of hospitalization or death in people age 65 or older, and those with certain chronic medical conditions, such as diabetes, heart disease, or obesity. Monoclonal antibody infusion received an emergency use authorization from the U.S. Food and Drug Administration in late 2020, following successful clinical trials at Penn Medicine and other institutions. 

    FULL STORY AT Penn Medicine News

  • The Penn Libraries acquires 15th century printing of the Sūtra of Perfection of Wisdom

    One of the newest additions to the collections of the Kislak Center for Special Collections, Rare Books, and Manuscripts is also the oldest printed book in the Penn Libraries—the 48th volume of the Daihannya haramitta-kyō (also known as Mahāprajñāpāramitā sūtra, or the Sūtra of Perfection of Wisdom).

    FULL STORY AT Penn Libraries

  • Penn Medicine launches region’s first post-COVID-19 neurological care clinic

    The Penn Neuro COVID Clinic aims to assess and treat long-haul COVID patients suffering from neurological symptoms, focusing on patients who previously tested positive for COVID-19 and experience symptoms related to cognition, headache, vertigo, and brain fog.

    FULL STORY AT Penn Medicine News

  • The Discovery Labs signs foundational lease with the Gene Therapy Program as anchor tenant

    Penn’s Gene Therapy Program will use Discovery Labs’ suburban campus for a portion of its expanding research operations focused on the  development of genetic medicines for rare and orphan diseases, as well as acquired and pandemic infectious diseases, such as COVID-19.

    FULL STORY AT Penn Medicine News

  • One Book, One SP2: Caste

    The Advisory Committee on Race and Social Justice has announced the selection of “Caste: The Origins of Our Discontents” by Isabel Wilkerson, as the One Book, One SP2 choice for 2021-2022. This book poignantly describes how the caste system originated, has been used in India, Nazi Germany, and the United States and still maintained today.

    FULL STORY AT School of Social Policy & Practice

  • African colonial and missionary records, plus South African Apartheid-era sources

    The Penn Libraries have acquired several digitized primary-source collections on British colonial Africa, Apartheid-era South Africa, and British missionary activities in African countries. These collections have been digitized from original sources by British Online Archives.

    FULL STORY AT Penn Libraries

  • Long-term suppression of hepatitis B in patients who are HIV-coinfected may lower cancer risk

    Research from a Penn Medicine study finds that suppressing detectable hepatitis B infection with the use of antiretroviral therapy cut the risk of developing liver cancer by 58%. These findings suggest that the best care for individuals with HIV and detectable hepatitis B includes sustained hepatitis B suppression with antiretroviral therapy.

    FULL STORY AT Penn Medicine News